|
NMRA Neumora Therapeutics Inc 1885522 |
| Balance Sheet |
|
Current Assets
|
314,055,000 |
|
Assets
|
316,972,000 |
|
Current Liabilities
|
29,886,000 |
|
Liabilities
|
29,908,000 |
|
Equity
|
287,064,000 |
|
Shares Out
|
160,028,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-182,936,000 |
|
Investing Cash Flow
|
-70,557,000 |
| Market Analysis |
Market Cap
|
1,886,726,576 |
|
Price
|
1.19 |
|
BVPS
|
1.79 |
|
PB
|
0.67 |
|
EPS
|
-1.66 |
|
PS
|
0.55 |
|
FCF
|
-253,493,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NMRA documents filed with the SEC.
NMRA Filings
Clear
